stars 1 stars 2 stars 3

Scinvivo enables optical biopsy for bladder cancer diagnostics. Current imaging techniques for bladder cancer have their limitations, as they only enable the urologist to visualise the bladder wall surface. In 30% of the cases, healthy tissue is incorrectly classified as cancerous. Another limitation is that it is difficult to fully remove a tumor during a surgical procedure, as the borders of the tumor are difficult to visualize. The last limitation is that it is impossible to determine the invasion depth of the tumor with current imaging technologies, while the invasion depth has major impact on the proposed treatment. All these limitation lead to unnecessary, invasive, and costly interventions. Scinvivos technology enables the urologist to improve diagnosis, and thus decreasing the amount of interventions, patient burden, and costs.

View Top Employees from Scinvivo B.V.

Scinvivo B.V. Questions

The Scinvivo B.V. annual revenue was $5.1 million in 2024.

Maaike de Jong is the Chief Medical Officer of Scinvivo B.V..

5 people are employed at Scinvivo B.V..

Scinvivo B.V. is based in Eindhoven, Noord-Holland.

The NAICS codes for Scinvivo B.V. are [6211, 621, 33, 62111, 339, 621111, 62].

The SIC codes for Scinvivo B.V. are [384, 801, 80, 38].

How It Works
Get a Free Account
Sign up for a free account. No credit card required. Up to 5 free lookups / month.
Search
Search over 700 million verified professionals across 35 million companies.
Get Contact Info
Get contact details including emails and phone numbers (business & personal).
High Performer Summer 2022 RocketReach is a leader in Lead Intelligence on G2 RocketReach is a leader in Lead Intelligence on G2 RocketReach is a leader in Lead Intelligence on G2
talentculture2022
g2crowd
G2Crowd Trusted
chromestore
300K+ Plugin Users